Study on the effect of cyclophosphamide on experimental rickettsial infection.
D000311:Adrenal Glands / Q000382:microbiology; D000372:Agglutination Tests; D000818:Animals; D000917:Antibody Formation; D003168:Complement Fixation Tests; D003381:Coxiella / Q000254:growth & development / Q000302:isolation & purification; D003520:Cyclophosphamide / Q000009:adverse effects*; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D007106:Immune Sera; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007279:Injections, Subcutaneous; D008099:Liver / Q000382:microbiology; D051379:Mice; D010537:Peritoneum / Q000382:microbiology; D011817:Rabbits; D012281:Rickettsia / Q000254:growth & development / Q000302:isolation & purification / Q000472:pathogenicity*; D012282:Rickettsia Infections / Q000209:etiology / Q000276:immunology* / Q000382:microbiology / Q000401:mortality; D012283:Rickettsia prowazekii / Q000254:growth & development / Q000302:isolation & purification; D013154:Spleen / Q000382:microbiology; D013552:Swine
D007106:Immune Sera; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide